Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RiverGlade Capital is a Chicago-based private equity firm focused on investing in lower middle market healthcare services companies in the United States. The firm partners with founders, entrepreneurs, and management teams to scale businesses serving patients, providers, payors, and local communities. Its investment focus appears to be services-oriented rather than drug discovery or therapeutic product development, with portfolio exposure in areas such as outpatient physical therapy, dental care, medical laboratory, behavioral health, and rehabilitation-related services. RiverGlade operates as an active healthcare-focused financial sponsor rather than a biotech, pharma, or medtech product company. It has raised multiple institutional funds and pursues control buyouts and select minority investments in growth-oriented healthcare businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RiverGlade Capital.